It has been announced that the largest ALS clinical trial data base, PRO-ACT, is now openly available to research around the world. Read more…
Trial News & Events
The 66th American Academy of Neurology Annual Meeting was held April 26th-May 3rd at the Pennsylvania Convention Center in Philadelphia, PA.
Results from the study BENEFIT-ALS were presented at the 66th AAN Meeting in Philadelphia, PA on April 29, 2014.
Harvard stem cell scientists have discovered that retigabine has effects in preclinical models of motor neuron disorder. The researchers are collaborating with Massachusetts General Hospital and the Northeast ALS Consortium to design an initial clinical trial in ALS. Click here for the full article.…
Former Springboks captain Joost Van der Westhuizen, who was diagnosed with ALS in 2011, will be traveling to the US to participate in ALS clinical studies. Read more >>…
The Northeast ALS Consortium is pleased to announce the results of the election for the Co-Chair, Investigator, and Evaluator positions on the NEALS Executive Committee.
The 12th Annual Meeting of NEALS was the largest and most information-packed meeting yet. Over 300 clinicians, nurses, therapists, and researchers came together to take stock of the many efforts being coordinated by NEALS, and to accelerate the pace of clinical research in ALS.
“Leading NEALS is one of the things in my professional career I am proudest of,” says Shefner.
The University City Science Center in Philadelphia has awarded Temple two proof-of-concept grants: one for the development of a novel therapy for the treatment of amyotrophic lateral sclerosis (ALS) and another for the creation of a software program that will hone physicians’ ability to read and diagnose electroencephalography, or EEGs.